Can premenstrual hormone shifts increase anxiety, sleep disturbance, night sweats, and autonomic symptoms?

Premenstrual shifts in estradiol and progesterone act as powerful triggers for neuropsychiatric and somatic distress in a subset of vulnerable women. Rather than representing abnormal absolute hormone levels, this vulnerability is a distinct neurosteroid sensitivity disorder.

Clinical and autonomic symptoms

• Anxiety and sleep disruption: Susceptible women experience heightened premenstrual anxiety alongside significant sleep-onset insomnia and frequent nocturnal awakenings during the late-luteal phase.
• Autonomic dysregulation: Impacted individuals exhibit decreased heart rate variability (HRV), representing reduced parasympathetic activity and elevated sympathetic tone during non-rapid eye movement sleep. While general autonomic instability (such as palpitations) is well-documented, specific data isolating premenstrual night sweats remains largely inferential.

Mechanistic pathways

• Allopregnanolone (ALLO) fluctuation: Premenstrual withdrawal of progesterone leads to rapid declines in its metabolite, ALLO, a potent positive allosteric modulator of GABA-A receptors.
• GABA-A receptor plasticity: Vulnerability lies in anomalous GABA-A receptor plasticity. In susceptible individuals, instead of promoting calming, sedative effects, fluctuating ALLO levels trigger paradoxical receptor destabilization, driving hyperarousal, anxiety, and vagal withdrawal under stress.

Bottom line

• Premenstrual hormone shifts trigger anxiety, sleep disturbances, and autonomic instability in susceptible women, a relationship driven by anomalous GABA-A receptor sensitivity to cyclical allopregnanolone fluctuations rather than hormone deficiencies.